29 Jun 2021 13:13
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | J.P. Morgan Securities LLC |
Company dealt in | Xeris Pharmaceuticals, Inc. |
Class of relevant security to which the dealings being disclosed relate (Note 2) | $0.001 common stock |
Date of dealing | 28 June 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities | 3,264,875 4.92 | 598,323 0.90 | ||||
(2) Derivatives (other than options) | 230,402 0.35 | 5,662 0.01 | ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total | 3,495,277 5.27 | 603,985 0.91 | ||||
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale |
Number of relevant securities |
Price per unit (USD)
(Note 5) |
Sale (Borrow Return)
Purchase ( Loan Return)
Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases
Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales | 58,400
114,700
199 100 200 400 1,100 1,071 200 4,272 1,300 2,024 323 4,826 31,616 11 3,000 13,334 1,900 1,100 5,662 400 300 1,200 500 380 282 400 560 200 48
199 201 411 2,300 1,500 400 585 3,400 500 1,595 1,333 7,845 1,150 2,700 900 3,300 2,100 100 1,701 4 1,071 4,225 901 31,616 11 400 3,168 5,662 4 | N/A
N/A
4.8100 USD 4.6700 USD 4.6500 USD 4.5988 USD 4.5918 USD 4.5818 USD 4.5800 USD 4.5735 USD 4.5700 USD 4.5699 USD 4.5695 USD 4.5686 USD 4.5679 USD 4.5645 USD 4.5637 USD 4.5618 USD 4.5553 USD 4.5445 USD 4.5376 USD 4.5375 USD 4.5367 USD 4.5275 USD 4.5160 USD 4.5158 USD 4.4948 USD 4.4850 USD 4.4800 USD 4.4750 USD 4.4700 USD
4.8100 USD 4.6900 USD 4.6873 USD 4.6800 USD 4.6700 USD 4.6600 USD 4.6500 USD 4.6453 USD 4.6400 USD 4.6300 USD 4.6285 USD 4.6264 USD 4.6200 USD 4.6100 USD 4.6089 USD 4.6069 USD 4.6000 USD 4.5950 USD 4.5900 USD 4.5825 USD 4.5818 USD 4.5800 USD 4.5700 USD 4.5679 USD 4.5645 USD 4.5600 USD 4.5500 USD 4.5376 USD 4.5225 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (USD) (Note 5) |
Equity Swap | Decrease Long
Opening a long position
Opening a short position | 31,616 1,071
11
5,662
| 4.5679 USD 4.5818 USD
4.5650 USD
4.5376 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition
or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure | 29 June 2021 |
Contact name | Alwyn Basch |
Telephone number | 0207 742 7407 |
If a connected EFM, name of offeree/offeror with which connected | N/A |
If a connected EFM, state nature of connection (Note 10) | N/A |